Globus Medical Posts Record Q4 Revenue Growth, Outlines 2026 Robotics Push
Globus Medical reported record Q4 2025 revenue growth and highlighted strategic investments to expand its spine portfolio. Management emphasized continued margin improvement and plans to accelerate advanced robotics deployment and enter new international markets in 2026.
1. Q4 Earnings Call Highlights
Globus Medical closed Q4 2025 with record revenue growth, driven by strong demand across its spine implant and orthopedics segments. Management noted sustained gross margin expansion from operational efficiencies and outlined plans to deploy advanced robotics platforms and expand into high-growth international markets throughout 2026.
Related News
NVDA
Nvidia Tops $91B Sales Forecast, Boosts Dividend and Buyback Program
NVDA•
NVDA
NVIDIA Forecasts Zero China Data Center Revenue, Targets $20B Vera CPU Sales
NVDA•
SVM
Silvercorp Secures 30-Year License Extension, Pays $60M for Tulkubash/Kyzyltash JV
SVM•
INTC
Nvidia’s $91B AI Forecast, $80B Buyback Ramps Up Pressure on Intel
INTC•
GROW
US Global Investors Sees 15% AUM Gain, 31% Revenue Growth and $2.6M Profit
GROW•
Sources
FF